Journal of Korean Society of Occupational and Environmental Hygiene (한국산업보건학회지)

Korean Industrial Hygiene Association (한국산업보건학회)
권호 표지
DOI QR코드

DOI QR Code

Seroprevalence of Hepatitis A and B Virus Antibody of Employees among Three Companies with Different Health Policy

사업장 보건관리에 따른 A형, B형 간염 항체 양성률

  • Koh, Hyun Min (Department of Family Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine) ;
  • Son, Jun Seok (Department of Occupational and Environmental Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine)
  • 고현민 (성균관대학교 의과대학 창원삼성병원 가정의학과) ;
  • 손준석 (성균관대학교 의과대학 창원삼성병원 직업환경의학과)
  • Received : 2015.04.23
  • Accepted : 2015.06.24
  • Published : 2015.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: We checked hepatitis A virus antibody(anti-HAV IgG) and hepatitis B virus antibody(HBsAb) in three large companies. The result could be a guideline to establish proper health policy for Hepatitis A and B virus preventive plan in company. Methods: We investigated the seroprevalence of anti-HAV IgG and HBsAb, and demographic characteristics of employee volunteer in three companies in southern area of Korea. Company was divided three according to health policy for hepatitis A and B. Results: The seroprevalence rate of anti-HAV IgG in company A, B, and C was 53.6%, 25.8%, and 17.7%(P<0.001), respectively. The seroprevalence rate of HBsAb in workplace A, B, and C was 79.7%, 82.4%, and 70.9%(P<0.001), respectively. Anti-HAV IgG showed more considerable difference among the companies. Conclusions: The results confirmed that low rate of IgG anti-HAV and HBsAb, particularly in the company that had low level of hepatitis education and vaccination program. This study was important for establishing hepatitis education policies, to prevent and control outbreaks in companies.

Keywords

References

  1. Bell BP, Feinstone SM. Hepatitis A. In: Plokin SA, Orenstein WA, eds. Vaccine. 4th ed. Philadelphia: WB Saunders,; 2004. p. 269-297
  2. Chisari FV, Ferrari C, Mondelli MU. Hepatitis B virus structure and biology. Microb Pathog 1989:6(5): 311-325 https://doi.org/10.1016/0882-4010(89)90073-9
  3. Choi W, Eom HS, Kim IH, Lee DH, Kim PS et al. Pattern of acute hepatitis A and anti-HAV seroprevalence of Kyungin province. Korean J Gastroenterol 1999; 34(1):69-75
  4. Chung SJ, Kim TY, Kim SM. Changes in the seroprevalance of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in korea. Clin Mol Hepatol 2014;20(2):162-167 https://doi.org/10.3350/cmh.2014.20.2.162
  5. Hong WS. Kim CY. Seroepidermiology of Type A and Type B hepatitis in Seoul area. Korean J Internal Med 1982;25(1):19-26
  6. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-6657 https://doi.org/10.1016/j.vaccine.2010.08.037
  7. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q 1984;11:1-47 https://doi.org/10.1177/109019818401100101
  8. Joo KR, Bang SJ, Song BC, Youn KH, Joo YH et al. Hepatitis B Viral Markers of Korean Adults in the Late 1990s : Survey Data of 70, 347 Health Screenees. Korean J Gastroenterol 1999;33(5):642-652
  9. Kim DS, Kim YS, Kim JY, Ahn YO. A study on the seropositivity of HBsAg Among biennial health examinees; a nation-wide multicenter survey. Korean J Prev Med 2002;35(2):129-135
  10. Kim JH, Kang JH, Lee SY, Choi HA, Kim HM et al. A study for seroprevalence of antibody to hepatitis A in Korea. Korean J Hepatol 2007;13(S):S27
  11. Kim TY, Sohn JH, Ahn SB, Son BK, Lee HL et al. Comparison of recent IgG Anti-HAV prevalence between two hospitals in Seoul and Gyeonggi area. Korean J Hepatol 2007;13(3):363-369 https://doi.org/10.3350/kjhep.2007.13.3.363
  12. Lee H, Cho HK, Kim JH, Kim KH. Seroepidemiology of Hepatitis A in Korea: Changes over the Past 30 Years. J Korean Med Sci 2011;26(6):791-796 https://doi.org/10.3346/jkms.2011.26.6.791
  13. Lee SJ, Na HY, Park MH, Park GS, Choi SK et al. A study on the change of HBsAg and Anti HBs positivies for a recent 15 year period in Korea. Korean J Hepatol 2001;7(3):299-307
  14. Maddrey WC. Hepatitis B: An important public health issue. J Med Virol 2000;61(3):362-366 https://doi.org/10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I
  15. Minor PD. Picornaviridae. In: Franki RIB, Fauquet CM,Knudson DL, Brown F, eds. Classification and nomenclature of viruses: fifth report of the international committee on taxonomy of viruses. Arch Virol 1991;S2:320-326
  16. Oh HY, Park JY. Immunization, knowledge, and preventive health behaviors to hepatitis A in university students. Korean J Health Educ Promot 2011;28:83-95
  17. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidermiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-2219 https://doi.org/10.1016/j.vaccine.2011.12.116
  18. Shin HS, Han KH, Park SJ, Ahn SK, Chon CY et al. The Prevalence of Hepatitis Virus infection & Clinical characteristics in patient with hepatocellular carcinoma. Korean J Med 1994;46(4):467-476
  19. Sim JG, Seo JK, Suh SJ. Prevalence and its changes of hepatitis B ciral markers from 1988 to 1993 in Korean children. J Korean Pediatr Soc 1995;38(11):1535-1539
  20. Sjogren MH. Hepatitis A. In: Feldman M, Friledman LS,Brandt LJ. eds. Sleigenser & Fordtran's gastrointestinaland liver disease. Vol 2. 8th ed. Philadelphia: Saunders.; 2006. p. 1639-1646
  21. World Health Organization. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec 2012;87: 261-267